Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has been updated to include the term 'Colorectal Cancer' and a new revision number, v2.15.0, while removing detailed descriptions of a study comparing regorafenib and fruquintinib.SummaryDifference16%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check85 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check100 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference3%
- Check107 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.2%
Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.